Evolus, Inc. Common Stock

Historical 13F Holders

Symbol
EOLS
CUSIP
30052C107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 30052C107 since 12/18/2024, largest first.

Filer % of Class Filed
Timothy P. Lynch 13G/A 9.9% 2/17/2026
Event 12/31/2025
Nantahala Capital Management, LLC 13G/A
8.9% 11/14/2025
Event 9/30/2025
BlackRock, Inc. 13G/A 6.9% 2/5/2025
Event 12/31/2024
Soleus Capital Master Fund, L.P. 13G
5.3% 8/31/2026
Event 8/27/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Perceptive Advisors LLC 13G/A
3.8% 8/14/2025
Event 6/30/2025
Medytox Inc. 13G/A 3.4% 2/6/2025
Event 12/31/2024
Tang Capital Management LLC 13G/A
1.9% 2/17/2026
Event 12/31/2025
Caligan Partners LP 13G/A
0% 2/17/2026
Event 12/31/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 4.52 k $36.1 k
2026 Q2 172 55.5 M $385 M
2026 Q1 156 45.7 M $188 M
2025 Q4 176 49.2 M $327 M
2025 Q3 169 54.9 M $337 M
2025 Q2 185 59.6 M $548 M
2025 Q1 188 54.3 M $653 M
2024 Q4 169 51.9 M $573 M
2024 Q3 172 50.5 M $817 M
2024 Q2 170 56.8 M $616 M
2024 Q1 179 56.5 M $791 M
2023 Q4 163 51.2 M $539 M
2023 Q3 147 41.5 M $379 M
2023 Q2 143 37.3 M $271 M
2023 Q1 134 35.1 M $297 M
2022 Q4 129 30.8 M $231 M
2022 Q3 136 26.3 M $212 M
2022 Q2 130 26.1 M $303 M
2022 Q1 126 24.7 M $275 M
2021 Q4 119 20.8 M $134 M
2021 Q3 126 17.6 M $135 M
2021 Q2 126 16.2 M $205 M
2021 Q1 106 8.61 M $112 M
2020 Q4 107 9.46 M $31.8 M
2020 Q3 104 7.30 M $28.8 M
2020 Q2 111 9.29 M $49.2 M
2020 Q1 120 14.3 M $59.0 M
2019 Q4 125 14.3 M $174 M
2019 Q3 107 5.66 M $88.5 M
2019 Q2 128 5.48 M $80.1 M
2019 Q1 109 3.95 M $89.3 M
2018 Q4 82 5.53 M $65.8 M
2018 Q3 75 6.94 M $129 M
2018 Q2 57 3.53 M $98.8 M
2018 Q1 42 4.45 M $40.2 M
2016 Q1 1 12.8 k $286 k